© 2022 MJH Life Sciences and Medical Economics. All rights reserved.
© 2022 MJH Life Sciences™ and Medical Economics. All rights reserved.
While private investments in early-stage companies have the potential for significant upside, they also carry significant risks. If adequate documentation is not available, proceed cautiously, if at all.
Medical research funding is critical, but many promising startups never reach clinical stages due to a lack of funds. However, the path has opened up for even the average investor.
Healthcare has been among the top performing sectors for the past 5 years. In the coming decade, what are the growth areas within healthcare to watch?
Physicians are in an excellent position to invest in the biotech and healthcare industry-not simply in mature public companies, but also early- and mid-stage private entities, some of which have significant growth potential.